Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes

J Blackman Northwood1, M Del Grosso, L R Cossins

  • 1Quotient Bioresearch Limited, Newmarket Road, Fordham CB7 5WW, United Kingdom. John.BlackmanNorthwood@quotientbioresearch.com

Insights

Macrolide efflux (mef) resistance in Streptococcus pyogenes is more diverse than previously known. New variants, including mef(I) and mosaic mef(A)-mef(E), were identified in respiratory infections, highlighting global mef(E) distribution.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Macrolide resistance is a growing concern in bacterial infections.
  • The mef (macrolide efflux) gene is a primary mechanism for macrolide resistance.
  • Streptococcus pyogenes is a common cause of community-acquired respiratory tract infections.

Purpose of the Study:

  • To characterize the macrolide efflux (mef) resistance mechanism in Streptococcus pyogenes.
  • To investigate the prevalence and diversity of mef genes in clinical isolates.

Main Methods:

  • Phenotypic screening of M phenotype isolates for mef genes.
  • Molecular characterization of novel mef variants and subclasses.

Main Results:

  • Fifty-four M phenotype isolates of S. pyogenes were analyzed.
  • mef(A) was negative in all tested isolates.
  • mef(E) was definitively present and globally distributed.
  • Novel variants mef(I) (0.4%) and a mosaic mef(A)-mef(E) (2.3%) were identified.
  • A novel subclass of mef was also detected (0.1%).

Conclusions:

  • Streptococcus pyogenes exhibits a diverse range of mef-mediated macrolide resistance mechanisms.
  • The presence of mef(E) and novel variants like mef(I) and mosaic mef(A)-mef(E) is significant.
  • These findings underscore the evolving landscape of antibiotic resistance in S. pyogenes.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...